Skip to main content
. 2017 Nov 29;8:886. doi: 10.3389/fphar.2017.00886

FIGURE 4.

FIGURE 4

The memory retention capabilities assessed by Probe trial in type 2 diabetic Goto–Kakizaki (GK) rats and non-diabetic Wistar rats 5 months after sevoflurane (SEV) or sham (control, CON) exposure. The number of original platform (the third quadrant) crossings (A) and the percent time spent in the third quadrant (B) were reduced in both groups of GK rats than Wistar rats. Moreover, the number of platform crossings and the percent time spent in the third quadrant were less in GK + SEV rats than those in GK + CON rats. Data are presented as mean ± SE (n = 10 for each group). P < 0.05 vs. respective Wistar rats; P < 0.05 vs. GK+CON rats.